Efranat

Israel
Reẖovot, Central District, Israel, 76701

Company profile

Efranat company profile

Efranat Ltd. was established in 2009 by, Prof. Nobuto Yamamoto, Boaz Shoam and Avi Levin. The Company was named after Avi and Boaz's wives, Efrat and Anat who died of cancer in 2009. A year before, during their quest to find a cure for their wives’ illness, Avi and Boaz met with Prof. Yamamoto, a world known researcher in the field of Cancer Immunotherapy. Prof. Yamamoto life's work was the discovery of a glycoprotein which he named "GcMAF" (Globulin component Macrophage Activating Factor) a molecule that activates Macrophages,to act against cancer cells.

Business identity

Contact email
[email protected]
Phone number
+972 897-2497
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2009-01-01, Year

Headquarters

Postal code
76701
Country code
IL
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
1
Total equity funding
$4.5M
Last funding
Series Unknown / $4.5M / 2014-11-19
Last equity funding
Series Unknown / $4.5M
Founders
2

Categories and groups

Founders and investors

Founders

Avi LevinBoaz Shoham